Read Summary

Cancer scientists in Britain are launching what they call the world’s first “Darwinian” drug development program in a bid to get ahead of cancer’s ability to become resistant to even the newest treatments and recur in many patients.
Reuters Health Information

Print Friendly, PDF & Email